92236 ⎘
Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#2Chiral diamine compounds for the preparation of chiral alcohols and chiral amines
#3Compounds that are S1P modulating agents and/or ATX modulating agents
#4Fused (hetero)cyclic compounds as S1P modulators
#5Unique dual-action therapeutics
#6ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS
#718-20 MEMBER BI-POLYCYCLIC COMPOUNDS
#8Serotonin receptor-targeting compounds and methods
#9Guanidine compounds and use thereof
#10SYSTEM AND METHOD FOR HYDROGENATING AROMATIC COMPOUND
#11Therapeutic compounds
#12N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#131,2-naphthoquinone based derivative and method of preparing the same
#14Alkenes as alkyne equivalents in radical cascades terminated by fragmentations
#15Compounds for use as GPR120 agonists
#16Photobase generators and photoresist compositions comprising same
#17Organic compound and organic light emitting device using the same
#18MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#19N-substituted benzamides and methods of use thereof
#20Cross-coupling of unactivated secondary boronic acids
#21Asymmetric catalytic decarboxylative alkyl alkylation using low catalyst concentrations and a robust precatalyst
#22Bicyclic compounds
#23Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase
#24Compounds useful as immunomodulators
#25Monomer, liquid crystal composition, liquid crystal display device, and production method for liquid crystal display device
#26Oxone-aceton mediated metal free preparation of syn-diols
#27Intermediate for synthesizing treprostinil diethanolamine and method for preparing the same
#28Quinone based nitric oxide donating compounds for ophthalmic use
#29IDO inhibitors
#30Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
#31α-Substituted glycinamide derivative
#32N-(4-(bis(4-(dimethylamino)phenyl)methylene)-8-(dimethylamino)
#33Condensed-cyclic compound and organic light-emitting diode including the same
#34Arylalkylamine compounds as calcium sensing receptor modulators
#35FULVIC ACID AND DERIVATIVES AND METHODS OF PREPARATION AND USE
#36Method for producing novel organometallic complex and amine compound
#37Fullerene derivative, organic solar cell using same, and manufacturing method thereof
#38Substituted bicyclic compounds
#39Synthetic building blocks for the production of materials for organic electroluminescence devices
#40Pesticidal compositions and processes related thereto
#41Liquid crystal compound having butene-bonding group, liquid crystal composition and liquid crystal display device
#42Pesticidal compositions and processes related thereto
#43Pesticidal compositions and processes related thereto
#44Guanidinobenzoic acid ester compound
#45Cycloalkyl-dione derivatives and methods of their use
#46Pesticidal compositions and processes related thereto
#47PREPARATION OF CHIRAL AMIDES AND AMINES
#48Resins for underlayers
#49Antagonists of the glucagon receptor
#50Liquid crystal compound, liquid crystal composition and liquid crystal display device
#51Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
#52Lysine specific demethylase-1 inhibitors and their use
#53Composition for treatment of pathogens that are resistant to tetracyclines
#54Coloring material and method for producing the same
#55Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
#56Bicyclic compounds
#57Therapeutic tetrahydronaphthalene compounds
#58UV CURED BENZOPHENONE TERMINATED QUARTERNARY AMMONIUM ANTIMICROBIALS FOR SURFACES
#59Method of treating cancer using selective estrogen receptor modulators
#60Integrated process for production of high octane gasoline, high aromatic naphtha and high cetane diesel from high aromatic middle distillate range streams
#61Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase
#62Tetralin and indane derivatives and uses thereof
#63Therapeutic agents
#64Use of a Compound for Inducing Differentiation of Mesenchymal Stem Cells into Cartilage Cells
#65Method for producing diisocyanates by phosgenating diamine suspensions
#66Compounds that are S1P modulating agents and/or ATX modulating agents
#67Aryloxyurea compound and pest control agent
#68Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions
#69Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
#70Method for producing ruthenium catalyst and method for producing alkyl group—or alkenyl group-substituted compound using ruthenium catalyst
#71Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease
#72Bicyclic compound
#73Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
#74Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#75Synthetic Epigallocatechin Gallate (EGCG) Analogs
#76Therapeutic compounds
#77Quinone based nitric oxide donating compounds
#78Therapeutic agents
#79Method for producing optically active alcohols
#80Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
#81Tetrahydronaphthalenyl compounds useful as sipi agonists
#82Lysine specific demethylase-1 inhibitors and their use
#83Pesticidal compositions and processes related thereto
#84Method for producing a pi-electron conjugated compound
#85Substituted naphthalenes as feedstock for plasticizer production
#86Organic electronic device containing an organic semiconductor material film which contains a leaving substituent-containing compound
#87Pesticidal compositions and processes related thereto
#88Pesticidal compositions and processes related thereto
#89Pesticidal compositions and processes related thereto
#90Pesticidal compositions and processes related thereto
#91Therapeutic compounds
#92Method of screening of therapeutic agents for K-Ras mutant driven cancers
#93Antagonists of the glucagon receptor
#94Pesticidal diaryl—heterocyclyl derivatives
#95Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
#96Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#97Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol
#98Aromatic acylation with cyclic anhydride for plasticizer production
#99Aromatic acylation with cyclic anhydride for plasticizer production
#100Heterobicyclic sphingosine 1-phosphate analogs
#101Quinone compounds for treating Ape1 mediated diseases
#102Organic compound and organic light emitting device using the same
#103Cyclopolyarylene compound and method of manufacturing same
#104Method of preparing (S)-2-amino-5-methoxytetralin hydrochloride
#105Polyphenol proteasome inhibitors, synthesis, and methods of use
#106Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#107Crystalline forms of a 3-carboxypropyl-aminotetralin compound
#108Preparation of norbornane-based PAC ballasts
#109Methods for making retinoids and uses thereof
#110N-substituted benzamides and methods of use thereof
#111N-substituted benzamides and methods of use thereof
#112Alpha, beta-unsaturated imines
#113Process for the synthesis of agomelatine
#114Process for the synthesis of agomelatine
#115Agomelatine intermediates and preparation method thereof
#116Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
#117Aryloxyurea compound and pest control agent
#118Arylamine compound
#119Chiral spiro-pyridylamidophosphine ligand compound, synthesis method therefor and application thereof
#120Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions
#121Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#122Benzocycloalkenes as antifungal agents
#123Process for the preparation of nitrogen substituted aminotetralins derivatives
#124Neuro-protective compounds and their use
#125Asymmetric hydrogenation method for ketone compound
#126Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives
#127Process for synthesis of amino-methyl tetralin derivatives
#128Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#129Radiation-sensitive resin composition, compound and producing method of compound
#130Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#131Tetralin and indane derivatives and uses thereof
#132Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#133Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
#134Fluorination of organic compounds
#1351,4-naphthoquinones derivatives and therapeutic use thereof
#136Nitrated hydrocarbons, derivatives, and processes for their manufacture
#137Catalyst systems and selective hydrogenation processes
#138Bis-(sulfonylamino) derivatives for use in therapy
#139Amine derivative having NPY Y5 receptor antagonistic activity
#140Polycyclic ring assembly compound and organic electroluminescent device employing the same
#141Amine derivative having NPY Y5 receptor antagonistic activity
#142CXCR2 inhibitors
#143Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
#144Synthesis and biological activity of bicyclic ABA analogs